Regulation of Cellular division in M. tuberculosis
结核分枝杆菌细胞分裂的调节
基本信息
- 批准号:7017688
- 负责人:
- 金额:$ 20.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:Mycobacterium tuberculosisbacterial geneticsbacterial proteinscell growth regulationchimeric proteinschromosomescytogeneticsgene expressiongene induction /repressiongenetic mappinggreen fluorescent proteinsmicroarray technologymicroorganism cultureoperonpolymerase chain reactionprotein localizationprotein protein interactionprotein structure functionproteomicssite directed mutagenesissynchronous cell divisiontemperature sensitive mutant
项目摘要
DESCRIPTION (provided by applicant):
This Proposal is in response to PA-01-113, "Therapeutics Research on AIDS-Associated Opportunistic Infections and Malignancies" and specifically addresses the study of Mycobacterium tuberculosis (MTB). The thrust of this proposal is the development of novel drug targets to counteract multiple drug resistant organisms. The long-term goal of this research program is to develop novel classes of chemotherapeutics that target the regulation, and coordination of chromosomal segregation and cellular division in MTB. Toward this objective we have identified in the MTB genome, gene products that are homologous to proteins associated with these processes in other prokaryotes. Moreover, our preliminary results provide strong evidence that some of these gene products (FtsZ and Ftsl homologues) actively participate in the cellular division of MTB. However, a more extensive analysis of these gene products and global assessment of the potential regulatory networks involved in the division of MTB cells are required. Similar to work with Caulobacter crescentus we hypothesize that DNA microarray analysis with synchronized cultures of MTB will allow us to develop a detailed pattern of gene expression profiles across the entire cell division cycle of this bacterium. Additionally, the use of known inhibitors of early (FtsZ activity) and late (Ftsl activity) events of cell division along with global gene expression studies will further elucidate the regulatory networks that are activated during different stages of cell division. A final analysis of putative regulatory genes already identified and new ones elucidated through gene expression profiling will enable us to develop a detailed picture of the regulatory networks and temporal gene expression responsible for MTB cellular division. Such studies will ensure that future resources are well directed at appropriate chemotherapeutic targets and developing suitable drug discovery strategies. Thus, the studies proposed in this application are designed to examine the replication dynamics of MTB, specifically focusing on cell cycle-regulated genes that are involved in cell division.
描述(由申请人提供):
该提案是对 PA-01-113“艾滋病相关机会性感染和恶性肿瘤的治疗研究”的回应,特别针对结核分枝杆菌 (MTB) 的研究。该提案的主旨是开发新的药物靶点来对抗多种耐药微生物。该研究计划的长期目标是开发针对 MTB 中染色体分离和细胞分裂的调节和协调的新型化疗药物。为了实现这一目标,我们在 MTB 基因组中鉴定出了与其他原核生物中与这些过程相关的蛋白质同源的基因产物。此外,我们的初步结果提供了强有力的证据,证明其中一些基因产物(FtsZ 和 Ftsl 同源物)积极参与 MTB 的细胞分裂。然而,需要对这些基因产物进行更广泛的分析,并对 MTB 细胞分裂中涉及的潜在调控网络进行全面评估。与新月柄杆菌的研究类似,我们假设使用 MTB 同步培养物进行 DNA 微阵列分析将使我们能够开发出该细菌整个细胞分裂周期中基因表达谱的详细模式。此外,使用已知的细胞分裂早期(FtsZ 活性)和晚期(Ftsl 活性)事件抑制剂以及全局基因表达研究将进一步阐明在细胞分裂不同阶段激活的调控网络。对已经确定的假定调节基因和通过基因表达谱阐明的新调节基因的最终分析将使我们能够详细了解负责 MTB 细胞分裂的调节网络和时间基因表达。此类研究将确保未来的资源能够很好地用于适当的化疗靶点并制定适当的药物发现策略。因此,本申请中提出的研究旨在检查 MTB 的复制动态,特别关注参与细胞分裂的细胞周期调节基因。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MadR1, a Mycobacterium tuberculosis cell cycle stress response protein that is a member of a widely conserved protein class of prokaryotic, eukaryotic and archeal origin.
MADR1,一种结核分枝杆菌细胞周期应力反应蛋白,是广泛保守的原核生物,真核和弓形的蛋白质类别的成员。
- DOI:10.1016/j.tube.2015.03.005
- 发表时间:2015-05
- 期刊:
- 影响因子:0
- 作者:Crew R;Ramirez MV;England K;Slayden RA
- 通讯作者:Slayden RA
Mycobacterium tuberculosis septum site determining protein, Ssd encoded by rv3660c, promotes filamentation and elicits an alternative metabolic and dormancy stress response.
- DOI:10.1186/1471-2180-11-79
- 发表时间:2011-04-19
- 期刊:
- 影响因子:4.2
- 作者:England K;Crew R;Slayden RA
- 通讯作者:Slayden RA
MazF6 toxin of Mycobacterium tuberculosis demonstrates antitoxin specificity and is coupled to regulation of cell growth by a Soj-like protein.
- DOI:10.1186/1471-2180-13-240
- 发表时间:2013-10-31
- 期刊:
- 影响因子:4.2
- 作者:Ramirez MV;Dawson CC;Crew R;England K;Slayden RA
- 通讯作者:Slayden RA
Discovery of anti-TB agents that target the cell-division protein FtsZ.
- DOI:10.4155/fmc.10.220
- 发表时间:2010-08
- 期刊:
- 影响因子:4.2
- 作者:Kumar K;Awasthi D;Berger WT;Tonge PJ;Slayden RA;Ojima I
- 通讯作者:Ojima I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD A SLAYDEN其他文献
RICHARD A SLAYDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD A SLAYDEN', 18)}}的其他基金
Development of novel broad spectrum chemotherapeutics against priority pathogens
针对主要病原体的新型广谱化疗药物的开发
- 批准号:
8261425 - 财政年份:2011
- 资助金额:
$ 20.97万 - 项目类别:
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense
用于生物防御的广谱抗菌剂的开发和配制
- 批准号:
7932903 - 财政年份:2009
- 资助金额:
$ 20.97万 - 项目类别:
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense
用于生物防御的广谱抗菌剂的开发和配制
- 批准号:
7645264 - 财政年份:2009
- 资助金额:
$ 20.97万 - 项目类别:
Development of novel broad spectrum chemotherapeutics against priority pathogens
针对主要病原体的新型广谱化疗药物的开发
- 批准号:
7675625 - 财政年份:2009
- 资助金额:
$ 20.97万 - 项目类别:
Development of Novel Chemotherapeutics Against F. tularensis
针对土拉杆菌的新型化疗药物的开发
- 批准号:
7688230 - 财政年份:2008
- 资助金额:
$ 20.97万 - 项目类别:
Regulation of Cellular division in M. tuberculosis
结核分枝杆菌细胞分裂的调节
- 批准号:
6863722 - 财政年份:2003
- 资助金额:
$ 20.97万 - 项目类别:
相似海外基金
Dissecting the bacterial genetics of bloodstream infection
剖析血流感染的细菌遗传学
- 批准号:
MR/X007197/1 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Fellowship
Redefining mobility in bacterial genetics and its impact on infectious disease.
重新定义细菌遗传学的流动性及其对传染病的影响。
- 批准号:
MR/X020223/1 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Research Grant
CSHL Advanced Bacterial Genetics Course
CSHL高级细菌遗传学课程
- 批准号:
1713681 - 财政年份:2017
- 资助金额:
$ 20.97万 - 项目类别:
Continuing Grant
CSHL Advanced Bacterial Genetics Course
CSHL高级细菌遗传学课程
- 批准号:
1346974 - 财政年份:2014
- 资助金额:
$ 20.97万 - 项目类别:
Continuing Grant
Development of new methodology in bacterial genetics and synthetic biology
细菌遗传学和合成生物学新方法的开发
- 批准号:
464216-2014 - 财政年份:2014
- 资助金额:
$ 20.97万 - 项目类别:
University Undergraduate Student Research Awards
Cold Spring Harbor Laboratory Advanced Bacterial Genetics Course
冷泉港实验室高级细菌遗传学课程
- 批准号:
0919304 - 财政年份:2009
- 资助金额:
$ 20.97万 - 项目类别:
Standard Grant
Cold Spring Harbor Laboratory ADVANCED BACTERIAL GENETICS COURSE
冷泉港实验室高级细菌遗传学课程
- 批准号:
0343656 - 财政年份:2004
- 资助金额:
$ 20.97万 - 项目类别:
Continuing Grant














{{item.name}}会员




